The global pandemic of COVID-19 is currently ongoing [1]. To date, pharmacological agents
used to treat patients with COVID-19 have been directed at avoiding and reducing the …

Monoclonal antibodies in the prophylaxis and treatment of COVID-19 have been crucial in
reducing severe infections when vaccines were unavailable. However, as the virus and its …

The novel coronavirus SARS-CoV-2 after emerging in China has caused a global pandemic
that is risking the lives of millions. COVID-19 has spread across the world at a very rapid rate …

Monoclonal antibodies are a promising treatment for COVID-19. However, the emergence of
SARS-CoV-2 variants raised concerns about these therapies' efficacy and long-term …

Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global
scientific community striving for solutions to the current pandemic. Characterizing humoral …

Abstract Coronavirus disease 2019 (COVID-19), reminiscent of the severe acute respiratory
syndrome (SARS) outbreak in 2003, has been a tragic disaster to people all over the world …

With the number of Coronavirus Disease 2019 (COVID-19) cases soaring worldwide and
limited vaccine availability for the general population in most countries, the monoclonal …

Monoclonal antibodies are a promising treatment for COVID-19. However, the emergence of
SARS-CoV-2 variants raised concerns about these therapies' efficacy and long-term …

The COVID-19 pandemic is the most serious health emergency of the twenty-first century, to
date causing approximately 106 million people to be infected and 2.32 million deaths …

Abstract Coronavirus disease 2019 (COVID-19) has developed as a pandemic, and it
created an outrageous effect on the current healthcare and economic system throughout the …